Alphatec (ATEC) delivered a strong fourth quarter with total revenue growing 21% year-over-year to $213 million. The company achieved a major milestone by generating positive free cash flow of $8 million in Q4 and $3 million for the full year, while expanding its adjusted EBITDA margin to 16%.

Alphatec Holdings, Inc. delivered a strong second quarter in 2025, with total revenue growing 27.5% to $186 million and surgical revenue increasing by 29% to $168 million. The company achieved non-GAAP net income profitability and significantly expanded its Adjusted EBITDA margin to 13%, reflecting disciplined execution and continued momentum in its procedural solutions.

Alphatec Holdings, Inc. reported strong financial results for the first quarter of 2025, with total revenue increasing by 22% and surgical revenue growing by 24%. The company also raised its full-year revenue and profitability guidance.

Alphatec Holdings, Inc. achieved a total revenue of $177 million in Q4 2024, demonstrating strong growth in surgical revenue by 28%. The company also reported a GAAP net loss of $33 million and generated $9 million in free cash flow, positioning itself for self-funded growth in the coming years.

Alphatec Holdings, Inc. announced strong financial results for the third quarter of 2024, with total revenue reaching $151 million, a 27% increase year-over-year. The company raised its full-year revenue guidance to $605 million and expects non-GAAP adjusted EBITDA of approximately $27 million.

Alphatec Holdings, Inc. reported a 25% increase in total revenue to $146 million for Q2 2024, driven by a 27% growth in surgical revenue. The company also raised its full-year revenue and profitability guidance.

Alphatec Holdings, Inc. reported strong first-quarter 2024 financial results, with total revenue growing 27% to $138 million and surgical revenue increasing by 30%. The company also raised its full-year revenue and adjusted EBITDA guidance to $601 million and $23 million, respectively.

Alphatec Holdings, Inc. reported Q4 2023 total revenue of $138 million. Full year 2023 total revenue grew 37% to $482 million. The company expects full year 2024 total revenue to approximate $595 million.

Alphatec Holdings, Inc. reported a 32% increase in total revenue, reaching $118 million for Q3 2023. Surgical revenue also grew by 32% to $104 million, and EOS revenue increased by 30% to $14 million. The company achieved positive adjusted EBITDA of over $2 million.

Alphatec Holdings, Inc. reported a 39% increase in total revenue to $117 million for the second quarter of 2023. Surgical revenue grew by 41% to $102 million, and EOS revenue increased by 24% to $15 million. The company also delivered positive adjusted EBITDA of over $1 million.

Alphatec Holdings, Inc. reported a 54% increase in total revenue, reaching $109 million for Q1 2023. Surgical revenue grew by 55%, and EOS revenue reached $15 million. The company's adjusted EBITDA margin improved by 1,080 basis points year-over-year. ATEC is maintaining its full-year 2023 revenue growth expectation of 28% to $450 million and anticipates achieving non-GAAP adjusted EBITDA break-even for the year.

Alphatec Holdings, Inc. reported a 43% increase in fourth-quarter revenue, reaching $106 million. The adjusted fourth-quarter EBITDA margin improved by 750 basis points year-over-year.

Alphatec Holdings, Inc. reported a 43% increase in total revenue to $90 million for the third quarter of 2022. The company also saw a 53% growth in surgical revenue and $11 million in EOS revenue. There was also a significant improvement in adjusted EBITDA year-over-year and sequentially.

Alphatec Holdings, Inc. reported strong second-quarter results, with total revenue growing by 35% to $84 million, including a 30% increase in organic revenue. The company's performance was driven by increased surgeon users and strong adoption of its products, leading to growth in revenue per surgery. ATEC also increased its full-year revenue guidance to $325 million, reflecting 34% growth.

Alphatec Holdings, Inc. reported a strong start to 2022 with a 61% increase in revenue, including 39% organic revenue growth. The company's full-year revenue guidance was increased to $316 million, reflecting 30% growth.

Alphatec Holdings, Inc. reported a strong Q4 and full year 2021, with record revenue and significant growth driven by the adoption of innovative spine surgery solutions and the integration of EOS imaging. The company's focus on surgeon trust and clinically distinct technology contributed to its sector-leading growth.

Alphatec Holdings, Inc. reported a strong third quarter with a 53% increase in total revenue, driven by organic growth and the adoption of the PTP technique. Revenue related to EOS imaging exceeded $11 million. The company is increasing its full year revenue guidance to $235 million.

Alphatec Holdings, Inc. reported strong second-quarter results with a 93% organic revenue growth. The company's revenue reached $62.2 million, and new products contributed significantly to the revenue. The acquisition of EOS imaging, S.A. was completed, and integration has commenced.

Alphatec Holdings, Inc. announced financial results for the quarter ended March 31, 2021. Total revenue was $44.1 million, with U.S. revenue reaching $43.7 million, reflecting a 50% growth. The company anticipates total revenue for the full year 2021 to be approximately $190 million.

Alphatec Holdings, Inc. reported a 38% increase in U.S. revenue for the fourth quarter and 30% for the full year. Revenue growth has averaged approximately 30% over the past eight quarters. The company's focus on surgeon adoption and sales footprint evolution has driven market share expansion.

Alphatec Holdings, Inc. reported a total revenue of $41.2 million for Q3 2020, with U.S. revenue contributing $40.1 million, representing a 43% year-over-year increase. The U.S. gross margin was 72.9%, and the company's cash and cash equivalents stood at $15.7 million as of September 30, 2020.

Alphatec Holdings reported a total revenue of $29.6 million for Q2 2020, with U.S. revenue reaching $28.8 million, an 11% increase year-over-year. The U.S. gross margin was 72.3%, and the company's cash and cash equivalents totaled $31.2 million as of June 30, 2020.

Alphatec Holdings, Inc. reported a total revenue of $30.1 million for Q1 2020, with U.S. revenue reaching $29.1 million, a 27% increase year-over-year. The company's U.S. gross margin was 72.1%, and it held $27.5 million in cash and cash equivalents as of March 31, 2020.

Alphatec Holdings, Inc. reported financial results for the fourth quarter and full year ended December 31, 2019. U.S. revenue grew nearly 30% year-over-year for the full year and 35% year-over-year in the fourth quarter.